Regulation of hypersensitivity

pathway activity — cross-omics
GO:0002883Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Regulation of hypersensitivity pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are BIN2, ARHGAP9, and MYO1F, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Regulation of hypersensitivity activity versus BIN2 in BRCA (Pearson r = 0.20).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCABIN2 →+0.673+0.679<.001<.00138
GBMARHGAP9 →+0.898+0.681<.001.00138
GBMMYO1F →+0.811+0.568<.001<.00138
OVWAS →+0.911+0.430<.001.00138
GBMLAPTM5 →+0.856+0.561<.001.00138
OVTNFRSF1B →+0.791+0.371.001.00438
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002883 vs BIN2 — BRCA

Per-sample scatter of Regulation of hypersensitivity activity vs BIN2 in BRCA.

Explore this scatter interactively →

Exploration